Skip to main content
. Author manuscript; available in PMC: 2016 Apr 8.
Published in final edited form as: J Nucl Med. 2014 May 22;55(7):1185–1191. doi: 10.2967/jnumed.114.138701

Table 1.

Regional VT and BPND values of 11C-LY2459989 under different conditions1

Condition Blocking Drug Dose (mg/kg) Globus pallidus Caudate Putamen Cingulate cortex Insula Frontal cortex Temporal cortex Thalamus Cerebellum
VT (mL·cm−3)
Baseline (n = 6) 12.7 ± 1.6 8.2 ± 1.4 8.1 ± 1.2 9.6 ± 2.0 8.4 ± 1.3 6.4 ± 1.0 6.1 ± 0.8 6.0 ± 0.9 4.0 ± 0.6
Naloxone (n = 2) 1.0 5.2 ± 0.6 4.9 ± 0.6 5.3 ± 0.8 4.9 ± 1.0 4.6 ± 0.7 4.4 ± 0.8 4.1 ± 0.5 4.8 ± 0.8 4.3 ± 0.6
LY2456302 (n = 1) 0.03 5.2 4.4 4.2 4.9 4.2 3.7 3.5 4.3 3.2
LY2456302 (n = 1) 0.3 4.2 4.2 4.4 4.2 3.8 3.7 3.7 4.2 3.8
LY2459989 (n = 2) 0.036 6.5 ± 2.1 5.3 ± 1.3 5.0 ± 0.8 5.6 ± 1.6 5.1 ± 1.3 4.5 ± 0.9 4.3 ± 0.6 4.9 ± 0.8 3.9 ± 0.1
11C–LY2795050 baseline (n = 4)2 5.2 ± 1.4 3.0 ± 1.4 4.2 ± 0.5 3.7 ± 1.4 3.4 ± 1.0 3.0 ± 1.1 2.8 ± 0.9 2.4 ± 0.6
BPND
Baseline (n = 6) 2.18 ± 0.23 1.04 ± 0.13 1.03 ± 0.15 1.39 ± 0.25 1.08 ± 0.09 0.59 ± 0.09 0.51 ± 0.08 0.50 ± 0.11
Naloxone (n = 2) 1.0 0.20 ± 0.04 0.13 ± 0.02 0.23 ± 0.00 0.14 ± 0.07 0.07 ± 0.01 0.02 ± 0.03 –0.03 ± 0.02 0.10 ± 0.03
LY2456302 (n = 1) 0.03 0.64 0.37 0.32 0.53 0.31 0.15 0.09 0.34
LY2456302 (n = 1) 0.3 0.09 0.10 0.16 0.11 0.01 –0.02 –0.04 0.12
LY2459989 (n = 2) 0.036 0.67 ± 0.22 0.36 ± 0.25 0.30 ± 0.19 0.44 ± 0.30 0.31 ± 0.23 0.16 ± 0.17 0.10 ± 0.11 0.25 ± 0.20
11C–LY2795050 baseline (n = 4)2 0.97 ± 0.10 0.32 ± 0.26 0.66 ± 0.25 0.63 ± 0.21 0.39 ± 0.17 0.30 ± 0.16 0.15 ± 0.12
1

Mean ± SD, where applicable;

2

Taken from reference (29).